Back to search

Azolla Biosystems Ltd

08263177

active
ltd
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)

Details

Beckett House Wyrefields, Poulton Industrial Estate, Poulton-Le-Fylde, FY6 8JX
Incorporated 22/10/2012

Compliance

Last accounts

31/10/2024

micro entity

Next accounts due

31/10/2026

On track

Confirmation statement

Last: 31/08/2025

Due 14/09/2026

On track

Industry

72110
Research and experimental development on biotechnology
74100
Specialised design activities
74901
Environmental consulting activities

Officers

Miss Alexandra Audrey Bujak

director · Since 20/11/2012

DIRECTOR

BRITISH · ENGLAND · Age 37

Mr Jonathan Bujak

director · Since 31/03/2020

DIRECTOR

BRITISH · ENGLAND · Age 78

Also on 2 other boards

Alexandra Audrey Bujak

director · Since 20/11/2012

British · England · Age 37

Jonathan Bujak

director · Since 31/03/2020

British · England · Age 78

Former

Jonathan Bujak

director · Resigned 23/11/2012

Julius Olalia Lopez

director · Resigned 31/10/2014

John Kenneth Stevens

director · Resigned 19/12/2016

Jonathan Bujak

director · Resigned 11/09/2018

Persons with Significant Control

Miss Alexandra Audrey Bujak

25–50% shares
25–50% votes

British · United Kingdom · Age 37

Beckett House, Wyrefields, Poulton-Le-Fylde, FY6 8JX

Notified 01/11/2018

Mr Jonathan Bujak

25–50% shares
25–50% votes
Appoint directors

British · United Kingdom · Age 78

Beckett House, Wyrefields, Poulton-Le-Fylde, FY6 8JX

Notified 23/08/2021

Former PSCs

Mr Jonathan Bujak

Ceased 01/11/2018

Change History

status → active
2026-07-14

Active

type → ltd
2026-07-14

Private Limited Company

address line1 → Beckett House Wyrefields
2026-07-14

BECKETT HOUSE WYREFIELDS

post town → Poulton-Le-Fylde
2026-07-14

POULTON-LE-FYLDE

CompanyRankvs 2076+ SIC 72110 peers
42

Financial strength16th percentile among SIC peers · 4/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio 0.29× · 2/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Cenobiologics Ltd
90
10Ccm Technologies Limited
90
2076Azolla Biosystems Ltd
41
How is this score calculated?
Financial strength4/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/10/2024

Net Worth

-£10k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

—

Working capital

Current Assets

£4k

Current Liabilities

£14k

1avg. employees

Balance Sheet

Assets less current liabilities-£10k
Signed by 8263177 2023-11-01 2024-10-31 8263177 2024-10-31 8263177 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 Prepared with Digita Accounts Production Advanced

EstimatesDerived

YearCurrent RatioImplied Profit
20240.29-£6k
20230.86—

Derived from filed accounts. Not audited figures.